A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank less in the lab at the trial’s end. A bonus: smokers smoked fewer cigarettes, too.

UW Health's Dr. Bill Hartman discusses a new study on Ozempic and alcohol cravings. For the first time since the start of the pandemic, flu deaths now outnumber COVID-19 deaths.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and lasted just over two months,

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 diabetes, may reduce alcohol cravings and consumption in adults with alcohol use disorder.

Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may help people cut down on drinking.